Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.0500 (-2.42%) ($5.9500 - $6.4000) on Wed. Nov. 30, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 47 | Latest Price | $6.0500(-2.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1% a day on average for past five trading days. | Weekly Trend | CGEN declines -3.4% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(5%) EWG(4%) URA(4%) TBT(3%) EWI(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.03% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
Resistance Level | $6.28 | 5 Day Moving Average | $6.14(-1.47%) | 10 Day Moving Average | $6.27(-3.51%) | 20 Day Moving Average | $6.28(-3.66%) | To recent high | -18.4% | To recent low | 8% | Market Cap | $500m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |